WASHINGTON, DC - APRIL 04: New Internal Revenue Commissioner Danny Werfel speaks during his swearing in ceremony at the IRS Headquarters on April 4, 2023 in Washington, DC. (Photo by Bonnie Cash/Getty ...
ST. LOUIS — The MetroLink has made operational changes after hearing from riders. Starting Monday, Dec. 4, during the day and normal hours it will be exactly like it was before. The plan follows the ...
PHOENIX--(BUSINESS WIRE)-- Carvana Co. (NYSE: CVNA), the leading e-commerce platform for buying and selling used cars, presented today at the William Blair 44th Annual Growth Stock Conference, sharing ...
Could The IRS 10-Year Strategic Operating Plan Lead To More Equitable Tax And Enforcement Practices?
In early April, the IRS released its 10-year strategic operating plan, a document that includes 42 key initiatives and 190 projects intended to transform how the agency delivers tax services. As part ...
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced a revised operating plan as it evaluates a range of strategic alternatives. The plan is aimed at preserving resources, ...
Last week, the Internal Revenue Service released the Strategic Operating Plan, which broadly lays out the agency's plans to use $80 billion in funding from the Inflation Reduction Act to transform the ...
This morning, the University released the details of its Operational Plan for Investing in Research, which aims to increase University research output over the next five to seven years through ...
The AICPA likes what it has seen so far in the IRS strategic operating plan for the $80 billion that Congress appropriated over 10 years as part of the Inflation Reduction Act of 2022, P.L. 117-169, ...
(1) See "Definitions of non-GAAP Measures and Metrics as Calculated by the Company" above. View original content to download multimedia:https://www.prnewswire.com ...
Targeting first approved product in 2026 towards realizing mission of bringing new, potential best-in-class treatments to patients with cancer Well-capitalized to support OnTarget 2026 initiatives ...
FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September 18, 2026 NDA submission for neladalkib in TKI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results